Collectively, these findings have underscored the significance of ‘personalized cancer medicine’, an evolving approach to cancer therapy that exploits the increasingly appreciated heterogeneous role of AhR-driven signaling among different subsets of patients. This evidence concerns the gene AHR and cancer.